🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well giving cyclophosphamide and anti-thymo...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2011-09-15
Trial ID
NCT01413100
Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause ...
Status
Recruiting
Location
University of California Los Angeles
Start Date
2010-04
Trial ID
NCT01060371
This randomized phase III trial compares two different high-dose chemothera...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2007-11-05
Trial ID
NCT00567567
Treatments Being Tested
This phase II trial studies the side effects of PD 0360324 and cyclophospha...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2018-12-31
Trial ID
NCT02948101
Treatments Being Tested
This phase II/III trial is studying the side effects and how well giving da...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2008-07-14
Trial ID
NCT00720109
Treatments Being Tested
This phase II trial studies how well talimogene laherparepvec and nivolumab...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2017-09-27
Trial ID
NCT02978625
This phase II trial studies how well stem cell transplant with or without t...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2017-10-12
Trial ID
NCT03317899
Treatments Being Tested
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Completed
Location
Addenbrooke's Hospital
Start Date
2010-07
Trial ID
NCT01222221
This study is about two chemotherapy study drug combinations (regimens) tha...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01639521
RATIONALE: Bexarotene may help cancer or abnormal cells become more like no...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-11
Trial ID
NCT00425477